MeSH D016470 - bacteremia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
No data
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Daptomycin | Daptomycin | 2016-03-25 | |||
| Padagis | Bacitracin, Polymyxin b | Bacitracin Polymyxin B | 2002-02-27 | |||
| Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Bacitracin-neomycin-polymyxin W/ Hydrocortisone | 1982-01-01 | ||||
| Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Bacitracin | 1982-01-01 | ||||
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone | 1989-07-31 | ||||
| Mylan | Daptomycin | Daptomycin | 2018-06-05 | |||
| GSK | Polymyxin b | Aerosporin | 1982-01-01 | |||
| Neomycin, Polymyxin b | Neosporin | 1985-01-14 | ||||
| Bacitracin, Polymyxin b | Polysporin | 1985-03-01 | ||||
| Sandoz | Dexamethasone, Neomycin, Polymyxin b | Maxitrol | 1984-05-22 | |||
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone | 1983-08-25 | ||||
| Tigecycline | Tigecycline | 2015-05-27 | ||||
| Trimethoprim, Polymyxin b | Trimethoprim Polymyxin B | 1998-04-13 | ||||
| Novartis | Dexamethasone, Neomycin, Polymyxin b | Dexacidin | 1984-10-29 | |||
| Bausch Health Companies | Bacitracin, Polymyxin b | Bacitracin Polymyxin B | 1995-01-26 | |||
| Dexamethasone, Neomycin, Polymyxin b | Dexasporin | 1995-09-13 | ||||
| Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Bacitracin | 1995-10-30 | ||||
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone | 1994-07-25 | ||||
| Gramicidin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Gramicidin | 1996-01-31 | ||||
| Hydrocortisone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Hydrocortisone | 1995-12-29 | ||||
| Hydrocortisone, Bacitracin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates, Bacitracin Hydrocortisone | 1995-10-30 | ||||
| Hydrocortisone, Neomycin, Polymyxin b | Oticair | 1996-08-28 | ||||
| Trimethoprim, Polymyxin b | Trimethoprim Polymyxin B | 1997-02-14 | ||||
| Merck & Co | Daptomycin | Cubicin | 2006-01-19 | $152 M | Y2020 | |
| Hydrocortisone, Neomycin, Polymyxin b | Otobione | 1982-01-01 | ||||
| Hydrocortisone, Polymyxin b | Otobiotic | 1982-01-01 | ||||
| Allergan | Prednisolone, Neomycin, Polymyxin b | Poly-pred | 1982-01-01 | |||
| Trimethoprim, Polymyxin b | Polytrim | 1988-10-20 | ||||
| Neomycin, Polymyxin b | Neomycin Polymyxin B | 1986-04-08 | ||||
| Gramicidin, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Gramicidin | 1987-06-11 | ||||
| Hydrocortisone, Neomycin, Polymyxin b | Otocort | 1982-01-01 | ||||
| Pfizer | Chloramphenicol, Polymyxin b | Chloromyxin | 1982-01-01 | |||
| Daptomycin | Daptomycin Hospira | 2017-03-22 | ||||
| Oxytetracycline, Polymyxin b | Terramycin W/ Polymyxin | 1982-01-01 | ||||
| Oxytetracycline, Polymyxin b | Terramycin-polymyxin | 1982-01-01 | ||||
| Tigecycline | Tygacil | 2006-04-24 | $202 M | Q4/18-Q3/21 |
1
2
3
4
5
6
>
Clinical Trials
Historical Success Rate
Phase 1
75%3/4
Phase 2
84%16/19
Phase 3
43%20/47
Approved: 6Overall Success rate: 27%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use